Nephros, Inc.
NEPH
$1.89
-$0.08-4.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.16M | 13.55M | 13.77M | 14.06M | 14.24M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.16M | 13.55M | 13.77M | 14.06M | 14.24M |
| Cost of Revenue | 5.44M | 5.28M | 5.46M | 5.58M | 5.83M |
| Gross Profit | 8.72M | 8.27M | 8.31M | 8.48M | 8.41M |
| SG&A Expenses | 7.68M | 8.22M | 8.63M | 8.93M | 8.91M |
| Depreciation & Amortization | 135.00K | 152.00K | 173.00K | 193.00K | 214.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.16M | 14.51M | 15.14M | 15.55M | 15.83M |
| Operating Income | 6.00K | -960.00K | -1.37M | -1.49M | -1.59M |
| Income Before Tax | 89.00K | -929.00K | -1.29M | -1.44M | -1.58M |
| Income Tax Expenses | 15.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.07 | -0.93 | -1.29 | -1.44 | -1.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.00K | -929.00K | -1.29M | -1.44M | -1.58M |
| EBIT | 6.00K | -960.00K | -1.37M | -1.49M | -1.59M |
| EBITDA | 143.00K | -807.00K | -1.19M | -1.29M | -1.38M |
| EPS Basic | 0.01 | -0.09 | -0.12 | -0.14 | -0.15 |
| Normalized Basic EPS | 0.01 | -0.06 | -0.08 | -0.09 | -0.09 |
| EPS Diluted | 0.00 | -0.09 | -0.13 | -0.14 | -0.15 |
| Normalized Diluted EPS | 0.01 | -0.06 | -0.08 | -0.09 | -0.09 |
| Average Basic Shares Outstanding | 42.10M | 42.04M | 41.96M | 41.75M | 41.54M |
| Average Diluted Shares Outstanding | 42.15M | 42.08M | 41.96M | 41.75M | 41.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |